Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Beuers

Showing results (271-280 of 298) with videos related to

Pageof 30
Sort By:
Hepatology Communications|December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisElisa Pose, Elsa Solà, Juan J Lozano, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2018
Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune HepatitisFloris F van den Brand, Koen S van der Veen, Ynto S de Boer, et al.
Journal of Hepatology|April 19, 2021
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitisMaria Reich, Lina Spomer, Caroline Klindt, et al.
Gastroenterology|December 1, 2009
Genome-wide association analysis in primary sclerosing cholangitisTom H Karlsen, Andre Franke, Espen Melum, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
The New England Journal of Medicine|August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
Plos One|September 3, 2010
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitisJohannes R Hov, Verena Keitel, Jon K Laerdahl, et al.
United European Gastroenterology Journal|June 20, 2020
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendationsJ-Matthias Löhr, Ulrich Beuers, Miroslav Vujasinovic, et al.
Pageof 30

Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
Hepatology Communications|December 29, 2021
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated CirrhosisElisa Pose, Elsa Solà, Juan J Lozano, et al.
Hepatology (Baltimore, Md.)|November 24, 2016
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort studyElisabeth M G de Vries, Manon de Krijger, Martti Färkkilä, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 7, 2018
Increased Mortality Among Patients With vs Without Cirrhosis and Autoimmune HepatitisFloris F van den Brand, Koen S van der Veen, Ynto S de Boer, et al.
Journal of Hepatology|April 19, 2021
Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitisMaria Reich, Lina Spomer, Caroline Klindt, et al.
Gastroenterology|December 1, 2009
Genome-wide association analysis in primary sclerosing cholangitisTom H Karlsen, Andre Franke, Espen Melum, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.
The New England Journal of Medicine|August 18, 2016
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Pietro Andreone, Giuseppe Mazzella, et al.
Plos One|September 3, 2010
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitisJohannes R Hov, Verena Keitel, Jon K Laerdahl, et al.
United European Gastroenterology Journal|June 20, 2020
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendationsJ-Matthias Löhr, Ulrich Beuers, Miroslav Vujasinovic, et al.
Pageof 30